Industry Supported Session Programs

Industry Supported Session Programs

Friday, November 16, 2018

12:00 – 13:30

Main Hall

CARDIOPROTECTION AND THE ROLE OF CARDIOXANE
Symposium Organized by:

CLINIGEN GROUP PLC

CHAIRS: Steven Lipshultz, USA & Hee Young Shin, Korea

12:00                WHO NEEDS CARDIOPROTECTION
Steven Lipshultz, USA

12:15                WHAT STRATEGIES ARE THE AVAILABLE FOR CARDIOPROTECTION
Jaume Mora, Spain

12:40                DEXRAZOXANE: CURRENT STATE OF THE EVIDENCE
Wayne Nicholls, Australia

13:05                CLINICAL EXPERIENCE WITH DEXRAZOXANE IN ASIA
Hee Young Shin, Korea

13:20                Q&A
Steven Lipshultz, USA & Hee Young Shin, Korea

 

 

Saturday, November 17, 2018

11:50-13:20

Main Hall

THERAPEUTIC CONSIDERATIONS FOR PATIENTS WITH HIGH-RISK NEUROBLASTOMA
Symposium Organized by:

EUSA

CHAIR:  Dr. Alice Yu, Taiwan

11:50                WELCOME AND INTRODUCTIONS
Dr. Alice Yu, Taiwan

11:55                HIGH-RISK NEUROBLASTOMA: CURRENT  TREATMENT OPTIONS AND INNOVATIONS IN US AND ASIA – COMMONALITIES, DISPARITIES AND REMAINING UNMET NEEDS
Dr. Alice Yu, Taiwan

12:15                INTRODUCING ANTI-GD2 AND ITS' IMMUNOMODULATORY NETWORK

Prof. Holger Lode, Germany

12:25                HIGH-RISK NEUROBLASTOMA: CURRENT SIOPEN TREATMENT STRATEGIES AND RESULTS IN EUROPE
Prof. Ruth Ladenstein,  Austria

12:40                POST-CONSOLIDATION THERAPY WITH ANTI-GD2 THERAPY: UNUSUAL AND CHALLENGING SCENARIOS

 Prof. Soh Shui Yen, Singapore

12:55                AUDIENCE Q&A
Dr. Alice Yu, Taiwan

13:10                SUMMARY AND CLOSE
Dr. Alice Yu, Taiwan

 



Keep Me Updated